Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
1(25%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
2
50%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution2 total trials
N/ANon-phased studies
2(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

4

all time

Status Distribution
Active(1)
Completed(2)
Other(1)

Detailed Status

Completed2
Recruiting1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
1
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A2 (100.0%)

Trials by Status

recruiting125%
completed250%
unknown125%

Recent Activity

1 active trials
Showing 4 of 4
recruitingnot_applicable

Immunometabolism of Machine Perfusion Strategies

NCT06371924
completed

Machine Perfusion in High vs Low/Mid-volume Liver Transplant Centers: a Multicentre Survey

NCT05662969
completednot_applicable

Hypothermic Oxygenated Perfusion Versus Static Cold Storage for Marginal Graft

NCT03031067
unknown

Prediction and Management of Delayed Graft Function Based on Donor Criteria and LifePort Platform

NCT02876692

Clinical Trials (4)

Showing 4 of 4 trials
NCT06371924Not Applicable

Immunometabolism of Machine Perfusion Strategies

Recruiting
NCT05662969

Machine Perfusion in High vs Low/Mid-volume Liver Transplant Centers: a Multicentre Survey

Completed
NCT03031067Not Applicable

Hypothermic Oxygenated Perfusion Versus Static Cold Storage for Marginal Graft

Completed
NCT02876692

Prediction and Management of Delayed Graft Function Based on Donor Criteria and LifePort Platform

Unknown

All 4 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
4